Literature DB >> 2828678

Encapsidation of Sendai virus genome RNAs by purified NP protein during in vitro replication.

S C Baker1, S A Moyer.   

Abstract

The ability of the Sendai virus major nucleocapsid protein, NP, to support the in vitro synthesis and encapsidation of viral genome RNA during Sendai virus RNA replication was studied. NP protein was purified from viral nucleocapsids isolated from Sendai virus-infected BHK cells and shown to be a soluble monomer under the reaction conditions used for RNA synthesis. The purified NP protein alone was necessary and sufficient for in vitro genome RNA synthesis and encapsidation from preinitiated intracellular Sendai virus defective interfering particle (DI-H) nucleocapsid templates. The amount of DI-H RNA replication increased linearly with the addition of increasing amounts of NP protein. With purified detergent-disrupted DI-H virions as the template, however, there was no genome RNA synthesis in either the absence or presence of the NP protein. Furthermore, addition of the soluble protein fraction of uninfected cells alone or in the presence of purified NP protein also did not support DI-H genome RNA synthesis from purified DI-H. Another viral component in addition to the NP protein appears to be required for the initiation of encapsidation, since the soluble protein fraction of infected but not uninfected cells did support DI-H genome replication from purified DI-H.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2828678      PMCID: PMC253639          DOI: 10.1128/JVI.62.3.834-838.1988

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  17 in total

1.  Plus and minus strand leader RNAs in negative strand virus-infected cells.

Authors:  M Leppert; L Rittenhouse; J Perrault; D F Summers; D Kolakofsky
Journal:  Cell       Date:  1979-11       Impact factor: 41.582

2.  Regulation of Sendai virus transcription: evidence for a single promoter in vivo.

Authors:  K Glazier; R Raghow; D W Kingsbury
Journal:  J Virol       Date:  1977-03       Impact factor: 5.103

3.  Determination by peptide mapping of the unique polypeptides in Sendai virions and infected cells.

Authors:  R A Lamb; P W Choppin
Journal:  Virology       Date:  1978-02       Impact factor: 3.616

4.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

5.  Interaction of VSV leader RNA and nucleocapsid protein may control VSV genome replication.

Authors:  B M Blumberg; M Leppert; D Kolakofsky
Journal:  Cell       Date:  1981-03       Impact factor: 41.582

6.  N protein of vesicular stomatitis virus selectively encapsidates leader RNA in vitro.

Authors:  B M Blumberg; C Giorgi; D Kolakofsky
Journal:  Cell       Date:  1983-02       Impact factor: 41.582

7.  Sequence of 3,687 nucleotides from the 3' end of Sendai virus genome RNA and the predicted amino acid sequences of viral NP, P and C proteins.

Authors:  T Shioda; Y Hidaka; T Kanda; H Shibuta; A Nomoto; K Iwasaki
Journal:  Nucleic Acids Res       Date:  1983-11-11       Impact factor: 16.971

8.  Sendai virus contains overlapping genes expressed from a single mRNA.

Authors:  C Giorgi; B M Blumberg; D Kolakofsky
Journal:  Cell       Date:  1983-12       Impact factor: 41.582

9.  Genomic and copy-back 3' termini in Sendai virus defective interfering RNA species.

Authors:  G G Re; K C Gupta; D W Kingsbury
Journal:  J Virol       Date:  1983-02       Impact factor: 5.103

10.  Preparation and analysis of the nucleocapsid proteins of vesicular stomatitis virus and sendai virus, and analysis of the sendai virus leader-NP gene region.

Authors:  B M Blumberg; C Giorgi; K Rose; D Kolakofsky
Journal:  J Gen Virol       Date:  1984-04       Impact factor: 3.891

View more
  13 in total

1.  Complexes of Sendai virus NP-P and P-L proteins are required for defective interfering particle genome replication in vitro.

Authors:  S M Horikami; J Curran; D Kolakofsky; S A Moyer
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

2.  Intranuclear inclusions in paramyxovirus-induced encephalitis: evidence for altered nuclear body differentiation.

Authors:  M Oglesbee
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

3.  Mutations in the 5' trailer region of a respiratory syncytial virus minigenome which limit RNA replication to one step.

Authors:  M E Peeples; P L Collins
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

4.  Leader sequence distinguishes between translatable and encapsidated measles virus RNAs.

Authors:  S J Castaneda; T C Wong
Journal:  J Virol       Date:  1990-01       Impact factor: 5.103

5.  Sendai virus NP gene codes for a 524 amino acid NP protein.

Authors:  W J Neubert; C Eckerskorn; H E Homann
Journal:  Virus Genes       Date:  1991-01       Impact factor: 2.332

6.  The NS1 protein of human respiratory syncytial virus is a potent inhibitor of minigenome transcription and RNA replication.

Authors:  P L Atreya; M E Peeples; P L Collins
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

7.  Expression of five proteins from the Sendai virus P/C mRNA in infected cells.

Authors:  P J Dillon; K C Gupta
Journal:  J Virol       Date:  1989-02       Impact factor: 5.103

8.  Purification and characterization of Nipah virus nucleocapsid protein produced in insect cells.

Authors:  Majid Eshaghi; Wen Siang Tan; Swee Tin Ong; Khatijah Yusoff
Journal:  J Clin Microbiol       Date:  2005-07       Impact factor: 5.948

Review 9.  Initiation and regulation of paramyxovirus transcription and replication.

Authors:  Sarah L Noton; Rachel Fearns
Journal:  Virology       Date:  2015-02-13       Impact factor: 3.616

10.  Measles virus synthesizes both leaderless and leader-containing polyadenylated RNAs in vivo.

Authors:  S J Castaneda; T C Wong
Journal:  J Virol       Date:  1989-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.